Guest post by Dr. Cathy Pietanza, a board-certified medical oncologist at Memorial Sloan Kettering Cancer Center in New York. She specializes in cancers that arise in the lungs and cares for a large number of patients with small cell lung cancer (SCLC).
Drs. Leora Horn, Ben Solomon, & Jack West consider the merits of administering immune checkpoint inhibitors concurrently with standard first line chemotherapy or targeted therapy vs. sequential treatment.
Drs. Leora Horn, Ben Solomon, & Jack West consider the merits of administering immune checkpoint inhibitors concurrently with standard first line chemotherapy or targeted therapy vs. sequential treatment.
Dr. Jack West asks the question of whether newer, more active ALK inhibitors such as alectinib should be used as first line therapy rather than for acquired resistance, including introducing the ALEX trial that is trying to answer this question.
Dr. Jack West asks the question of whether newer, more active ALK inhibitors such as alectinib should be used as first line therapy rather than for acquired resistance, including introducing the ALEX trial that is trying to answer this question.
Please advice! I have UTI and 2 different organisms are detected and only macrodantine antibiotic is applicable for both. I am on Tarceva treatment at...
I had stage 1 lung cancer. Had lobectomy 11 weeks ago. Removed bottom two lobes, right lung. No chemo needed. Taking Cymbalta for nerve pain and it...
My 79 yo uncle was just diagnosed with NSCLC Adenocarcinoma. Waiting for an oncologist appointment set for July 19th, in the meantime here is his PET...
If you struggling with depression or going thru a tuff time in your life maybe trying to seek spiritual help would help you like it helped me...
My husband was recently dx'd with stage 4 lung ca due to metastatic pleural effusion, of which he has a permanent chest tube in place with approx 600...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.